The effect of p-4E-BP1 and p-eIF4E on cell proliferation in a breast cancer model
Pons López, Berta (Universitat Autònoma de Barcelona. Departament de Bioquímica i de Biologia Molecular)
Peg, Vicente 
(Hospital Universitari Vall d'Hebron)
Vázquez-Sánchez, María Ángeles (Hospital Universitari Vall d'Hebron)
López-Vicente, Laura (Hospital Universitari Vall d'Hebron)
Argelaguet, Elisabet (Hospital Universitari Vall d'Hebron)
Coch, Laura (Hospital Universitari Vall d'Hebron)
Martínez, Alba (Hospital Universitari Vall d'Hebron)
Hernandez-Losa, Javier
(Hospital Universitari Vall d'Hebron)
Armengol, Gemma
(Universitat Autònoma de Barcelona. Departament de Biologia Animal, de Biologia Vegetal i d'Ecologia)
Ramón y Cajal, Santiago
(Hospital Universitari Vall d'Hebron)
| Data: |
2011 |
| Resum: |
Cell signaling pathways and protein translation are crucial for understanding malignant transformation. 4E-BP1 and the eIF4F complex regulate cap-dependent translation. We investigated how 4E-BP1 and eIF4E phosphorylation status affects in vitro and in vivo cell proliferation in a breast cancer model. Cells from 2 breast carcinoma lines (MDA-MB 231 and MDA-MB 468) and human fibroblasts (IMR90 cells) were infected in vitro with a retrovirus carrying a wild-type 4E-BP1 or a mutant 4E-BP1 unable to hyperphosphorylate. Overexpression of the mutant 4E-BP1 induced a significant decrease in cell proliferation in IMR90 and MDA-MB 468 cells, but not in MDA-MB 231 cells. A correlation was observed between baseline-phosphorylated eIF4E (p-eIF4E) levels and sensitivity to 4E-BP1 transduction. By co-immunoprecipitation, p-eIF4E seemed to present lower affinity for 4E-BP1 than total eIF4E in MDA-MB 468 cells. After treatment with CGP57380, the MAP kinase-interacting kinase (MNK) inhibitor, downregulation of p-eIF4E levels was associated with an increase of E-cadherin and β-catenin protein expression. These results provide evidence that 4E-BP1 transduction leads to a decrease in cell proliferation, and that high p-eIF4E levels may counteract the suppressor effect of 4E-BP1. We propose that high p-4E-BP1 and p-eIF4E levels are central factors in cell signaling and reflect the oncogenic potential of cell signaling pathways in breast cancer. |
| Ajuts: |
Agència de Gestió d'Ajuts Universitaris i de Recerca 2005/SGR-00144 Fundació la Marató de TV3 052710
|
| Drets: |
Aquest material està protegit per drets d'autor i/o drets afins. Podeu utilitzar aquest material en funció del que permet la legislació de drets d'autor i drets afins d'aplicació al vostre cas. Per a d'altres usos heu d'obtenir permís del(s) titular(s) de drets.  |
| Llengua: |
Anglès |
| Document: |
Article ; recerca ; Versió publicada |
| Matèria: |
4E-binding protein 1 ;
Breast cancer ;
E-cadherin ;
Eukaryotic initiation factor 4E ;
Protein translation ;
Β-catenin ;
SDG 3 - Good Health and Well-being |
| Publicat a: |
International Journal of Oncology, Vol. 39, issue 5 (Novmber 2011) , p. 1337-1345, ISSN 1791-2423 |
DOI: 10.3892/ijo.2011.1118
El registre apareix a les col·leccions:
Articles >
Articles de recercaArticles >
Articles publicats
Registre creat el 2025-10-16, darrera modificació el 2026-02-26